Sorted By:

Relevance


The Washington Post retracts PhRMA claim in opioid story

PhRMA  |  Blog Post

Earlier this week, The Washington Post falsely claimed that the PhRMA supported the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 and spent $40 million advocating for its enactment.
http://catalyst.phrma.org/the-washington-post-retracts-phrma-claim-in-opioid-story

Enhancing Today's STEM Workforce to Ensure Tomorrow's New Medicines

PhRMA  |  Report

In fact, one of the most important elements of success for the innovative biopharmaceutical sector is the talented people who dedicate their lives to the discovery, development, and manufacturing of new treatments and cures to meet the needs of America’s patients.
https://www.phrma.org

A critical opportunity to prevent prescription drug abuse

PhRMA  |  Blog Post

As someone who has spent the bulk of my career focused on issues related to substance abuse, including more than 10 years with PhRMA and prior to that almost 8 years in the White House Drug Policy Office, I am heartened to see the FDA commit to helping solving this problem.
http://catalyst.phrma.org/a-critical-opportunity-to-prevent-prescription-drug-abuse

New Analysis: 340B Program Shifting Delivery of Physician-Administered Medicines to More Expensive Hospital Settings

PhRMA  |  Press Release

This shift in site of care can have significant consequences for Medicare and privately insured patients whose insurance does not fully cover their costs and leaves them with a share of the bill.
https://www.phrma.org/press-release/new-analysis-340b-program-shifting-delivery-of-physician-administered-medicines-to-more-expensive-hospital-settings

Access to Rheumatoid Arthritis Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

For an analysis of health insurance exchange coverage in 2015, view this fact sheet.
http://www.accessbettercoverage.org/factsheets/access-to-rheumatoid-arthritis-medicines-in-exchange-plans

Access to Oncology Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

For an analysis of health insurance exchange coverage in 2015, view this fact sheet.
http://www.accessbettercoverage.org/factsheets/access-to-oncology-medicines-in-exchange-plans

Medicare Monday: Catch up on MedPAC and its Part B recommendations

PhRMA  |  Blog Post

For policy wonks, you can get up to speed with our Memorial Day reading list on the Medicare Payment Advisory Commission (MedPAC), how it informs Medicare policy and its recent Part B recommendations, which are expected to be included in their report to Congress this June.
http://catalyst.phrma.org/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations

Access to Diabetes Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

For an analysis of health insurance exchange coverage in 2015, view this fact sheet.
http://www.accessbettercoverage.org/factsheets/access-to-diabetes-medicines-in-exchange-plans

Leading Biopharmaceutical Researchers to Showcase the New Era of Medicine on Capitol Hill

PhRMA  |  Press Release

“The science has never been more promising and it’s critical we have policies that not only sustain the remarkable progress we have seen, but also foster the next generation of therapies to fight disease.”
https://www.phrma.org/press-release/leading-biopharmaceutical-researchers-to-showcase-the-new-era-of-medicine-on-capitol-hill

Burden on Patients: Looking Ahead

PhRMA  |  Blog Post

Asthma Blog: Access to Asthma Medicine and the Risk of Going Without By the Numbers Graphic: Asthma Fact Sheet: Access to Asthma Medicines in Exchanges Rheumatoid Arthritis Blog: Preserving the ‘New Normal’ for Patients with Rheumatoid Arthritis By the Numbers Graphic: Rheumatoid Arthritis Fact Sheet: Access to Rheumatoid Arthritis Medicines in Exchanges Diabetes Blog: Prescription Management is Critical for Diabetes Patients By the Numbers Graphic: Diabetes Fact Sheet: Access to Diabetes Medicines in Exchanges HIV/AIDS  Blog: Two Steps Forward and One Step Back for HIV/AIDS Patients By the Numbers Graphic: HIV/AIDS Fact Sheet: Access to HIV/AIDS Medicines in Exchanges Mental Health Disorders Blog: Mental Health Disorders Can Affect Anyone and Health Insurance Exchanges Must Provide Needed Medicines By The Numbers Graphic: Mental Health  Fact Sheet: Access to Mental Health Medicines in Exchanges Multiple Sclerosis Blog: One-Size-Fits-All Approach to Treating Multiple Sclerosis Hurts Patients By the Numbers Graphic: MS Fact Sheet: Access to Multiple Sclerosis Medicines in Exchanges Oncology Blog: Limiting Access to Necessary Medicines Threatens Hope for Oncology Patients By the Numbers Graphic: Oncology Fact Sheet: Access to Oncology Medicines in Exchanges
http://catalyst.phrma.org/burden-on-patients-looking-ahead-2014

Access to Hepatitis Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

This fact sheet provides insights into how plans in the health insurance exchanges and employer plans cover hepatitis medicines.
http://www.accessbettercoverage.org/factsheets/access-to-hepatitis-medicines-in-exchange-plans

Together - Cancer

PhRMA  |  Video

See how a two-week old targeted therapy drug has now created a link between them. 
https://www.phrma.org/video/together-cancer

PhRMA CEO in Forbes - How to negotiate better deals for prescription medicines

PhRMA  |  Blog Post

In fact, a new PhRMA-commissioned analysis by Amundsen Consulting found that more than half of patients’ out-of-pocket spending for brand medicines is based on the list price of the medicine, even though their health insurance company may be receiving a steep discount.
http://catalyst.phrma.org/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

Hopefully you’ve had the chance to meet Salim and Roxanne from our Together series on GoBoldly.com.
http://catalyst.phrma.org/going-boldly-together-new-advancements-and-new-anniversaries

Biopharmaceutical Company Communications with Health Care Stakeholders

PhRMA  |  Report

According to a recent survey of payer executives and specialty physicians conducted by Health Strategies Group, both payers and providers are interested in additional information from biopharmaceutical companies about prescription medicines – including information about pipeline medicines and una...
https://www.phrma.org/report/biopharmaceutical-company-communications-with-health-care-stakeholders

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

PhRMA  |  Press Release

Reuters November 4, 2016; Silverman E, What the “Shocking” Gilead Discounts on its Hepatitis C Drugs Will Mean, Wall Street Journal, February 4, 2015; Barrett P, Langreth R, The Crazy Math Behind Drug Prices: Intermediaries that Negotiate to Lower Prices May Cause Them To Increase Too, Bloomberg Businessweek, June 29, 2017.
https://www.phrma.org/press-release/phrma-statement-on-comments-to-cms-regarding-proposed-part-d-rule-and-rfi-exploring-pass-through-rebates-to-seniors-at-point-of-sale

Access to Asthma Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

For an analysis of health insurance exchange coverage in 2015, view this fact sheet.
http://www.accessbettercoverage.org/factsheets/access-to-asthma-medicines-in-exchange-plans

Access to Hyperlipidemia Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

This fact sheet provides insights into how plans in the health insurance exchanges and employer plans cover hyperlipidemia medicines.
http://www.accessbettercoverage.org/factsheets/access-to-hyperlipidemia-medicines-in-exchange-plans

Access to Cystic Fibrosis Medicines in Exchange Plans

Access Better Coverage  |  From Our Network

This fact sheet provides insights into how plans in the health insurance exchanges and employer plans cover cystic fibrosis medicines.
http://www.accessbettercoverage.org/factsheets/access-to-cystic-fibrosis-medicines-in-exchange-plans

Director– Policy and Research

PhRMA  |  PhRMA Career

Accordingly, the successful candidate should be adaptable, able to reprioritize and shift gears quickly.
https://www.phrma.org

Medicare Monday: Looking back at the success of Part D in its first 10 years

PhRMA  |  Blog Post

In fact, multiple studies have found about 90 percent or more of beneficiaries are satisfied with their Part D coverage.
http://catalyst.phrma.org/looking-back-at-the-success-of-part-d-in-its-first-10-years

Burden on Patients: Access to Medicines in Exchange Plans

PhRMA  |  Blog Post

Check out the 2015 Burden on Patients series posts highlighted below: Mental Health Disorders Blog: Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans Graphic: Utilization Management Applied to Mental Health Medicines Fact Sheet: Access to Mental Health Medicines in Exchange Plans   HIV/AIDS Blog: Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans Graphic: Placing All HIV Medicines on a Specialty Tier Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to HIV/AIDS Medicines in Exchange Plans  Oncology Blog: Burden on Patients: Questions on Access to Cancer Medicines in Health Exchange Plans Graphic: Utilization Management Applied to Oncology Innovator Medicines Fact Sheet: Access to Oncology Medicines in Exchange Plans Asthma Blog: Burden on Patients: 5 Questions on Access to Asthma Medicines in Health Exchange Plans Graphic: Utilization Management for Asthma Medicines Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to Asthma Medicines in Exchange Plans Diabetes Blog: Burden on Patients: 5 Questions on Access to Diabetes Medicines in Health Exchange Plans Graphic: Utilization Management for Diabetes Medicines Could Be a Barrier to Access in Health Insurance Exchange Plans Fact Sheet: Access to Diabetes Medicines in Exchange Plans Multiple Sclerosis Blog: Burden on Patients: 5 Questions on access to multiple sclerosis medicines in health exchange plans Fact Sheet: Access to Multiple Sclerosis Medicines in Exchange Plans Rheumatoid Arthritis Blog: Burden on Patients: 5 Questions on access to rheumatoid arthritis medicines in health exchange plans Graphic: Increasingly Placing Rheumatoid Arthritis Medicines on a Specialty Tier Could Be a Barrier to Access Fact Sheet: Access to Rheumatoid Arthritis Medicines in Exchange Plans
http://catalyst.phrma.org/burden-on-patients-access-to-medicines-in-exchange-plans

The risks of counterfeit imported medicines

PhRMA  |  Blog Post

Over the years, we’ve seen counterfeit cancer drugs as well as opioids enter the United States illegally with deadly consequences.
http://catalyst.phrma.org/the-risks-of-counterfeit-imported-medicines

Guest Contributor: Debra of America on Epidermolysis Bullosa

PhRMA  |  Blog Post

I would like people to see those living with rare disease as people with the same emotions and thoughts as everyone else, who live with a certain set of challenges that life dictates they overcome. 
http://catalyst.phrma.org/guest-contributor-debra-of-america-on-epidermolysis-bullosa

Medicare Monday: A closer look at Part B spending

PhRMA  |  Blog Post

In fact, Part B drug spending has historically been a stable share of overall Part B spending and is expected to remain so in the future.
http://catalyst.phrma.org/medicare-monday-a-closer-look-at-part-b-spending

You have reviewed the first 200 results out of 1200. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 12 next